Cargando…
Preventive Effect of Quercetin in a Triple Transgenic Alzheimer’s Disease Mice Model
Alzheimer’s disease (AD) is the most common type of dementia and is the leading cause of disability in elderly people worldwide. Current pharmacological therapies do not cure the disease, and for this reason, some pharmacotherapy studies have investigated preventive treatments focused on modifiable...
Autores principales: | Paula, Pérez-Corredor, Angelica Maria, Sabogal-Guáqueta, Luis, Carrillo-Hormaza, Gloria Patricia, Cardona-Gómez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630340/ https://www.ncbi.nlm.nih.gov/pubmed/31226738 http://dx.doi.org/10.3390/molecules24122287 |
Ejemplares similares
-
Inverse Phosphatidylcholine/Phosphatidylinositol Levels as Peripheral Biomarkers and Phosphatidylcholine/Lysophosphatidylethanolamine-Phosphatidylserine as Hippocampal Indicator of Postischemic Cognitive Impairment in Rats
por: Sabogal-Guáqueta, Angelica Maria, et al.
Publicado: (2018) -
Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer’s mice
por: Castro-Alvarez, John F., et al.
Publicado: (2014) -
Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease
por: Muñoz-Cabrera, Jonathan Mauricio, et al.
Publicado: (2019) -
Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis
por: Oh, Kwang-Jin, et al.
Publicado: (2010) -
Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice
por: Bittner, Tobias, et al.
Publicado: (2010)